Mopidamol
Code | Size | Price |
---|
TAR-T25829-1mg | 1mg | £376.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T25829-5mg | 5mg | £785.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T25829-10mg | 10mg | £1,058.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T25829-25mg | 25mg | £1,540.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T25829-50mg | 50mg | £1,821.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T25829-100mg | 100mg | £2,319.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Mopidamol, a derivative of dipyridamole, is a phosphodiesterase inhibitor that has been exhibited previously to limit progression of malignancy in certain experimental animal models and in a pilot study in humans.
CAS:
13665-88-8
Formula:
C19H31N7O4
Molecular Weight:
421.502
Pathway:
Metabolism
Purity:
0.98
SMILES:
OCCN(CCO)c1ncc2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO
Target:
PDE
References
1. Blaha H, Dierkesmann R, Feuerer W, Gatzemaier U, Geser C, Lemme J, Mall W, Ritscher R, Schneider B, Vallee D. [Adjuvant therapy of non-small cell bronchial cancer with mopidamol]. Pneumologie. 1989 Jun;43(6):299-304. German. PubMed PMID: 2547216.
2. Zacharski LR, Moritz TE, Baczek LA, Rickles FR, Edwards RL, Forman WB, Forcier RJ, Cornell CJ, Haakenson CM, Ballard HS, et al. Effect of mopidamol on survival in carcinoma of the lung and colon: final report of Veterans Administration Cooperative Study No. 188. J Natl Cancer Inst. 1988 Mar 16;80(2):90-7. PubMed PMID: 2830407.
3. Mopidamol. J Natl Cancer Inst. 1988 Jun 1;80(7):532-4. PubMed PMID: 2835491.
4. Livingston RB. Mopidamol in non-small cell lung cancer: anti-oncogene or accident? J Natl Cancer Inst. 1988 Mar 16;80(2):77-8. PubMed PMID: 2830406.